{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T20:56:49Z","timestamp":1760821009293},"reference-count":28,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.transproceed.2018.07.033","type":"journal-article","created":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T16:46:23Z","timestamp":1533833183000},"page":"3460-3466","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Preformed C1q-binding Donor-specific Anti-HLA Antibodies and Graft Function After Kidney Transplantation"],"prefix":"10.1016","volume":"50","author":[{"given":"Y.","family":"Okabe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Kaku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Tsuchimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Masutani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2018.07.033_bib1","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1053\/j.ajkd.2008.06.005","article-title":"A\u00a0systematic review of kidney transplantation from expanded criteria donors","volume":"52","author":"Pascual","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transproceed.2018.07.033_bib2","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1399-3046.2004.00214.x","article-title":"Transplanting patients with a positive donor-specific crossmatch: a single center\u2019s perspective","volume":"8","author":"Montgomery","year":"2004","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.transproceed.2018.07.033_bib3","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1111\/j.1600-6143.2008.02441.x","article-title":"Alloantibody levels and acute humoral rejection early after positive crossmatch kidney transplantation","volume":"8","author":"Burns","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2018.07.033_bib4","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJMoa0707894","article-title":"Rituximab and intravenous immune globulin for desensitization during renal transplantation","volume":"359","author":"Vo","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2018.07.033_bib5","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJM196904032801401","article-title":"Significance of the positive crossmatch test in kidney transplantation","volume":"280","author":"Patel","year":"1969","journal-title":"New Engl J Med"},{"key":"10.1016\/j.transproceed.2018.07.033_bib6","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1681\/ASN.2009101065","article-title":"Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation","volume":"21","author":"Lefaucheur","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2018.07.033_bib7","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1097\/TP.0b013e3181f6a07b","article-title":"Pretransplant donor-specific antibodies detected by single-antigen bead flow cytometry are associated with inferior kidney transplant outcomes","volume":"90","author":"Singh","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2018.07.033_bib8","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/j.1600-6143.2011.03985.x","article-title":"Pretransplant donor-specific HLA class-I and -II antibodies are associated with an increased risk for kidney graft failure","volume":"12","author":"Otten","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2018.07.033_bib9","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.humimm.2009.04.011","article-title":"Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant","volume":"70","author":"Aubert","year":"2009","journal-title":"Hum Immunol"},{"key":"10.1016\/j.transproceed.2018.07.033_bib10","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/TP.0b013e3182100f77","article-title":"No association of kidney graft loss with human leukocyte antigen antibodies detected exclusively by sensitive Luminex single-antigen testing: a Collaborative Transplant Study report","volume":"91","author":"S\u00fcsal","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2018.07.033_bib11","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1365-2249.1991.tb02954.x","article-title":"Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection","volume":"86","author":"Feucht","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.transproceed.2018.07.033_bib12","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1681\/ASN.V10102208","article-title":"Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries","volume":"10","author":"Collins","year":"1999","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2018.07.033_bib13","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1681\/ASN.V1341091","article-title":"Capillary C4d deposition in kidney allografts: a specific marker of alloantibody-dependent graft injury","volume":"13","author":"B\u00f6hmig","year":"2002","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2018.07.033_bib14","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.healun.2010.08.020","article-title":"Clinical usefulness of a novel C1q assay to detect immunoglobulin G antibodies capable of fixing complement in sensitized pediatric heart transplant patients","volume":"30","author":"Chin","year":"2011","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2018.07.033_bib15","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.transproceed.2013.11.011","article-title":"Significance of C1q-fixing donor-specific antibodies after kidney transplantation","volume":"46","author":"Thammanichanond","year":"2014","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2018.07.033_bib16","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/TP.0b013e318203fd26","article-title":"C1q-fixing human leukocyte antigen antibodies are specific for predicting transplant glomerulopathy and late graft failure after kidney transplantation","volume":"91","author":"Yabu","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2018.07.033_bib17","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa1302506","article-title":"Complement-binding anti-HLA antibodies and kidney-allograft survival","volume":"369","author":"Loupy","year":"2013","journal-title":"New Engl J Med"},{"key":"10.1016\/j.transproceed.2018.07.033_bib18","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.transproceed.2015.12.116","article-title":"Role of pretransplant complement-fixing donor-specific antibodies identified by C1q assay in kidney transplantation","volume":"48","author":"Thammanichanond","year":"2016","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2018.07.033_bib19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.trim.2013.07.002","article-title":"Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter?","volume":"29","author":"Crespo","year":"2013","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.transproceed.2018.07.033_bib20","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/ndt\/gfv391","article-title":"Pre-transplant donor-specific anti-human leukocyte antigen antibodies are associated with high risk of delayed graft function after renal transplantation","volume":"31","author":"Per\u00e4saari","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2018.07.033_bib21","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00007890-198808000-00007","article-title":"Early function as the principal correlate of graft survival. A multivariate analysis of 200 cadaveric renal transplants treated with a protocol incorporating antilymphocyte globulin and cyclosporine","volume":"46","author":"Halloran","year":"1988","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2018.07.033_bib22","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/ajt.12590","article-title":"Banff 2013 meeting report: inclusion of C4d-negative antibody-mediated rejection and antibody-associated arterial lesions","volume":"14","author":"Haas","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2018.07.033_bib23","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/ajt.12589","article-title":"Diagnosis and management of antibody-mediated rejection: current status and novel approaches","volume":"14","author":"Djamali","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2018.07.033_bib24","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1084\/jem.178.2.661","article-title":"Structural features of human immunoglobulin G that determine isotype-specific differences in complement activation","volume":"178","author":"Tao","year":"1993","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.transproceed.2018.07.033_bib25","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.humimm.2013.01.008","article-title":"Significant IgG subclass heterogeneity in HLA-specific antibodies: implications for pathogenicity, prognosis, and the rejection response","volume":"74","author":"Lowe","year":"2013","journal-title":"Hum Immunol"},{"key":"10.1016\/j.transproceed.2018.07.033_bib26","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3390\/antib3010130","article-title":"From donor to recipient: current questions relating to humoral alloimmunization","volume":"3","author":"Prigent","year":"2014","journal-title":"Antibodies"},{"key":"10.1016\/j.transproceed.2018.07.033_bib27","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1111\/ajt.13700","article-title":"Acquisition of C3d-binding activity by de novo donor-specific HLA antibodies correlates with graft loss in nonsensitized pediatric kidney recipients","volume":"16","author":"Comoli","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2018.07.033_bib28","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/01.ccx.0000146119.46547.05","article-title":"Delayed graft function in renal transplantation","volume":"10","author":"Peeters","year":"2004","journal-title":"Curr Opin Crit Care"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134518310625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134518310625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T00:08:52Z","timestamp":1661731732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134518310625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0041134518310625"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2018.07.033","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preformed C1q-binding Donor-specific Anti-HLA Antibodies and Graft Function After Kidney Transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2018.07.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}